Cargando…
Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933181/ https://www.ncbi.nlm.nih.gov/pubmed/31891147 http://dx.doi.org/10.1016/j.eclinm.2019.11.009 |